MYCO Profile
- Sector: Health Technology
- Industry: Pharmaceuticals
Mydecine Innovations Group, Inc. is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. The company encompasses three companies: Mindleap Health, Mydecine Health Sciences, and NeuroPharm Inc. The Mindleap Health is an advanced digital health platform that helps people connect with mental health specialists who can empower them to thrive and develop habits for a healthy mind. The Mydecine Health Sciences is a vertically integrated company developing novel fungtional mushroom products and psychedelic medicines for healthy and vulnerable populations. The NeuroPharm is developing a unique and proprietary set of pharmaceutical and natural health products addressing mental wellness in vulnerable populations. The company was founded by Parente Carman on September 27, 2013 and is headquartered in Vancouver, Canada.
https://s3.tradingview.com/external-embedding/embed-widget-mini-symbol-overview.js https://s3.tradingview.com/external-embedding/embed-widget-financials.jsRecent News
- Cresco Labs Announces the Appointment of Tarik Brooks to Its Board of Directors and the Retirement of Dominic Sergi
- NeonMind Announces New Specialty Clinics Division to Deliver Innovative Mental Health Services, Appoints New VP, Corporate Development
- Myconic Capital Announces Closing of Mindscape Ketamine & Infusions Therapy Acquisition
- Verano to Add Cultivation and Fortify Retail Capacity in Pennsylvania
- Planet 13 Crushes Single-Day Record in Las Vegas with Historic 420 Return
- The Valens Company Increases Domestic Reach with Distribution Agreement with Yukon Territory
- Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107
- Lord Jones™ Debuts “A Higher Order”
- Novamind Collaborates with Center for Change
- Canopy Growth Signs U.S. Distribution Agreement with Southern Glazer’s Wine & Spirits for CBD Beverage Portfolio
